 | • レポートコード：MRC2-11QY12073 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は大発作のグローバル市場について調査・分析したレポートです。種類別（バルビツール酸塩、ヒダントイン、フェニルトリアジン、イミノスチルベン、ベンゾジアゼピン、脂肪族カルボン酸、その他）市場規模、用途別（病院、クリニック、学術・研究センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別大発作の競争状況、市場シェア ・世界の大発作市場：種類別市場規模 2015年-2020年（バルビツール酸塩、ヒダントイン、フェニルトリアジン、イミノスチルベン、ベンゾジアゼピン、脂肪族カルボン酸、その他） ・世界の大発作市場：種類別市場規模予測 2021年-2026年（バルビツール酸塩、ヒダントイン、フェニルトリアジン、イミノスチルベン、ベンゾジアゼピン、脂肪族カルボン酸、その他） ・世界の大発作市場：用途別市場規模 2015年-2020年（病院、クリニック、学術・研究センター、その他） ・世界の大発作市場：用途別市場規模予測 2021年-2026年（病院、クリニック、学術・研究センター、その他） ・北米の大発作市場分析：米国、カナダ ・ヨーロッパの大発作市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの大発作市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の大発作市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの大発作市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Johnson & Johnson、UCB Celltech、Abbott Laboratories、GlaxoSmithKline、Novartis、Sanofi、Takeda、Teva Pharmaceutical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Epilepsy is a group of neurological disorders characterized by brief, involuntary episodes of vigorous shaking of a part or complete body. The patient may experience loss or disturbance of consciousness and movements along with sensory or psychiatric disturbances. Grand mal seizures or tonic–clonic seizures are a type of generalized seizures, which affect the entire brain and are the most common type of epileptic seizures. Grand mal seizures are caused by neurotransmitter imbalances, which can also be influenced by fatigue, lack of sleep, hypertension, stress, intense lighting, rapid motion, blood sugar level, anxiety, etc. The grand mal seizures consist of two phases, the tonic phase and the clonic phase. The tonic phase involves loss of consciousness and muscle twitching and the phase usually last only for a few seconds. The clonic phase consists of rapid muscle contraction and relaxation resulting in convulsions.
The Americas accounts for the significant market share owing to extensive use of medications and greater expenditure on the health care. Additionally, the fastest uptake of new technology and drugs in the US drives the global grand mal seizures market. The concentration of the major medical diagnostic device manufacturers in the developed regions is also adding fuel to the market. Europe is the second largest market due to a high disposable income and rising awareness about the grand mal seizures.
Market Analysis and Insights: Global Grand Mal Seizure Market
The global Grand Mal Seizure market size is projected to reach US$ 20400 million by 2026, from US$ 19890 million in 2020, at a CAGR of 2.4%% during 2021-2026.
Global Grand Mal Seizure Scope and Market Size
Grand Mal Seizure market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Grand Mal Seizure market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Pfizer
Johnson & Johnson
UCB Celltech
Abbott Laboratories
GlaxoSmithKline
Novartis
Sanofi
Takeda
Teva Pharmaceutical
Market segment by Type, the product can be split into
Barbiturates
Hydantoin
Phenyltriazine
Iminostilbenes
Benzodiazepines
Aliphatic Carboxylic Acid
Others
Market segment by Application, split into
Hospitals
Clinics
Academic and Research Centers
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Grand Mal Seizure Revenue
1.4 Market by Type
1.4.1 Global Grand Mal Seizure Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Barbiturates
1.4.3 Hydantoin
1.4.4 Phenyltriazine
1.4.5 Iminostilbenes
1.4.6 Benzodiazepines
1.4.7 Aliphatic Carboxylic Acid
1.4.8 Others
1.5 Market by Application
1.5.1 Global Grand Mal Seizure Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Academic and Research Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Grand Mal Seizure Market Perspective (2015-2026)
2.2 Global Grand Mal Seizure Growth Trends by Regions
2.2.1 Grand Mal Seizure Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Grand Mal Seizure Historic Market Share by Regions (2015-2020)
2.2.3 Grand Mal Seizure Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Grand Mal Seizure Market Growth Strategy
2.3.6 Primary Interviews with Key Grand Mal Seizure Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Grand Mal Seizure Players by Market Size
3.1.1 Global Top Grand Mal Seizure Players by Revenue (2015-2020)
3.1.2 Global Grand Mal Seizure Revenue Market Share by Players (2015-2020)
3.1.3 Global Grand Mal Seizure Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Grand Mal Seizure Market Concentration Ratio
3.2.1 Global Grand Mal Seizure Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Grand Mal Seizure Revenue in 2019
3.3 Grand Mal Seizure Key Players Head office and Area Served
3.4 Key Players Grand Mal Seizure Product Solution and Service
3.5 Date of Enter into Grand Mal Seizure Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Grand Mal Seizure Historic Market Size by Type (2015-2020)
4.2 Global Grand Mal Seizure Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Grand Mal Seizure Market Size by Application (2015-2020)
5.2 Global Grand Mal Seizure Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Grand Mal Seizure Market Size (2015-2020)
6.2 Grand Mal Seizure Key Players in North America (2019-2020)
6.3 North America Grand Mal Seizure Market Size by Type (2015-2020)
6.4 North America Grand Mal Seizure Market Size by Application (2015-2020)
7 Europe
7.1 Europe Grand Mal Seizure Market Size (2015-2020)
7.2 Grand Mal Seizure Key Players in Europe (2019-2020)
7.3 Europe Grand Mal Seizure Market Size by Type (2015-2020)
7.4 Europe Grand Mal Seizure Market Size by Application (2015-2020)
8 China
8.1 China Grand Mal Seizure Market Size (2015-2020)
8.2 Grand Mal Seizure Key Players in China (2019-2020)
8.3 China Grand Mal Seizure Market Size by Type (2015-2020)
8.4 China Grand Mal Seizure Market Size by Application (2015-2020)
9 Japan
9.1 Japan Grand Mal Seizure Market Size (2015-2020)
9.2 Grand Mal Seizure Key Players in Japan (2019-2020)
9.3 Japan Grand Mal Seizure Market Size by Type (2015-2020)
9.4 Japan Grand Mal Seizure Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Grand Mal Seizure Market Size (2015-2020)
10.2 Grand Mal Seizure Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Grand Mal Seizure Market Size by Type (2015-2020)
10.4 Southeast Asia Grand Mal Seizure Market Size by Application (2015-2020)
11 India
11.1 India Grand Mal Seizure Market Size (2015-2020)
11.2 Grand Mal Seizure Key Players in India (2019-2020)
11.3 India Grand Mal Seizure Market Size by Type (2015-2020)
11.4 India Grand Mal Seizure Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Grand Mal Seizure Market Size (2015-2020)
12.2 Grand Mal Seizure Key Players in Central & South America (2019-2020)
12.3 Central & South America Grand Mal Seizure Market Size by Type (2015-2020)
12.4 Central & South America Grand Mal Seizure Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Grand Mal Seizure Introduction
13.1.4 Pfizer Revenue in Grand Mal Seizure Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Details
13.2.2 Johnson & Johnson Business Overview
13.2.3 Johnson & Johnson Grand Mal Seizure Introduction
13.2.4 Johnson & Johnson Revenue in Grand Mal Seizure Business (2015-2020)
13.2.5 Johnson & Johnson Recent Development
13.3 UCB Celltech
13.3.1 UCB Celltech Company Details
13.3.2 UCB Celltech Business Overview
13.3.3 UCB Celltech Grand Mal Seizure Introduction
13.3.4 UCB Celltech Revenue in Grand Mal Seizure Business (2015-2020)
13.3.5 UCB Celltech Recent Development
13.4 Abbott Laboratories
13.4.1 Abbott Laboratories Company Details
13.4.2 Abbott Laboratories Business Overview
13.4.3 Abbott Laboratories Grand Mal Seizure Introduction
13.4.4 Abbott Laboratories Revenue in Grand Mal Seizure Business (2015-2020)
13.4.5 Abbott Laboratories Recent Development
13.5 GlaxoSmithKline
13.5.1 GlaxoSmithKline Company Details
13.5.2 GlaxoSmithKline Business Overview
13.5.3 GlaxoSmithKline Grand Mal Seizure Introduction
13.5.4 GlaxoSmithKline Revenue in Grand Mal Seizure Business (2015-2020)
13.5.5 GlaxoSmithKline Recent Development
13.6 Novartis
13.6.1 Novartis Company Details
13.6.2 Novartis Business Overview
13.6.3 Novartis Grand Mal Seizure Introduction
13.6.4 Novartis Revenue in Grand Mal Seizure Business (2015-2020)
13.6.5 Novartis Recent Development
13.7 Sanofi
13.7.1 Sanofi Company Details
13.7.2 Sanofi Business Overview
13.7.3 Sanofi Grand Mal Seizure Introduction
13.7.4 Sanofi Revenue in Grand Mal Seizure Business (2015-2020)
13.7.5 Sanofi Recent Development
13.8 Takeda
13.8.1 Takeda Company Details
13.8.2 Takeda Business Overview
13.8.3 Takeda Grand Mal Seizure Introduction
13.8.4 Takeda Revenue in Grand Mal Seizure Business (2015-2020)
13.8.5 Takeda Recent Development
13.9 Teva Pharmaceutical
13.9.1 Teva Pharmaceutical Company Details
13.9.2 Teva Pharmaceutical Business Overview
13.9.3 Teva Pharmaceutical Grand Mal Seizure Introduction
13.9.4 Teva Pharmaceutical Revenue in Grand Mal Seizure Business (2015-2020)
13.9.5 Teva Pharmaceutical Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Grand Mal Seizure Key Market Segments
Table 2. Key Players Covered: Ranking by Grand Mal Seizure Revenue
Table 3. Ranking of Global Top Grand Mal Seizure Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Grand Mal Seizure Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Barbiturates
Table 6. Key Players of Hydantoin
Table 7. Key Players of Phenyltriazine
Table 8. Key Players of Iminostilbenes
Table 9. Key Players of Benzodiazepines
Table 10. Key Players of Aliphatic Carboxylic Acid
Table 11. Key Players of Others
Table 12. Global Grand Mal Seizure Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Grand Mal Seizure Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Grand Mal Seizure Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Grand Mal Seizure Market Share by Regions (2015-2020)
Table 16. Global Grand Mal Seizure Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Grand Mal Seizure Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Grand Mal Seizure Market Growth Strategy
Table 22. Main Points Interviewed from Key Grand Mal Seizure Players
Table 23. Global Grand Mal Seizure Revenue by Players (2015-2020) (Million US$)
Table 24. Global Grand Mal Seizure Market Share by Players (2015-2020)
Table 25. Global Top Grand Mal Seizure Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Grand Mal Seizure as of 2019)
Table 26. Global Grand Mal Seizure by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Grand Mal Seizure Product Solution and Service
Table 29. Date of Enter into Grand Mal Seizure Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Grand Mal Seizure Market Size by Type (2015-2020) (Million US$)
Table 32. Global Grand Mal Seizure Market Size Share by Type (2015-2020)
Table 33. Global Grand Mal Seizure Revenue Market Share by Type (2021-2026)
Table 34. Global Grand Mal Seizure Market Size Share by Application (2015-2020)
Table 35. Global Grand Mal Seizure Market Size by Application (2015-2020) (Million US$)
Table 36. Global Grand Mal Seizure Market Size Share by Application (2021-2026)
Table 37. North America Key Players Grand Mal Seizure Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Grand Mal Seizure Market Share (2019-2020)
Table 39. North America Grand Mal Seizure Market Size by Type (2015-2020) (Million US$)
Table 40. North America Grand Mal Seizure Market Share by Type (2015-2020)
Table 41. North America Grand Mal Seizure Market Size by Application (2015-2020) (Million US$)
Table 42. North America Grand Mal Seizure Market Share by Application (2015-2020)
Table 43. Europe Key Players Grand Mal Seizure Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Grand Mal Seizure Market Share (2019-2020)
Table 45. Europe Grand Mal Seizure Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Grand Mal Seizure Market Share by Type (2015-2020)
Table 47. Europe Grand Mal Seizure Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Grand Mal Seizure Market Share by Application (2015-2020)
Table 49. China Key Players Grand Mal Seizure Revenue (2019-2020) (Million US$)
Table 50. China Key Players Grand Mal Seizure Market Share (2019-2020)
Table 51. China Grand Mal Seizure Market Size by Type (2015-2020) (Million US$)
Table 52. China Grand Mal Seizure Market Share by Type (2015-2020)
Table 53. China Grand Mal Seizure Market Size by Application (2015-2020) (Million US$)
Table 54. China Grand Mal Seizure Market Share by Application (2015-2020)
Table 55. Japan Key Players Grand Mal Seizure Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Grand Mal Seizure Market Share (2019-2020)
Table 57. Japan Grand Mal Seizure Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Grand Mal Seizure Market Share by Type (2015-2020)
Table 59. Japan Grand Mal Seizure Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Grand Mal Seizure Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Grand Mal Seizure Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Grand Mal Seizure Market Share (2019-2020)
Table 63. Southeast Asia Grand Mal Seizure Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Grand Mal Seizure Market Share by Type (2015-2020)
Table 65. Southeast Asia Grand Mal Seizure Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Grand Mal Seizure Market Share by Application (2015-2020)
Table 67. India Key Players Grand Mal Seizure Revenue (2019-2020) (Million US$)
Table 68. India Key Players Grand Mal Seizure Market Share (2019-2020)
Table 69. India Grand Mal Seizure Market Size by Type (2015-2020) (Million US$)
Table 70. India Grand Mal Seizure Market Share by Type (2015-2020)
Table 71. India Grand Mal Seizure Market Size by Application (2015-2020) (Million US$)
Table 72. India Grand Mal Seizure Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Grand Mal Seizure Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Grand Mal Seizure Market Share (2019-2020)
Table 75. Central & South America Grand Mal Seizure Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Grand Mal Seizure Market Share by Type (2015-2020)
Table 77. Central & South America Grand Mal Seizure Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Grand Mal Seizure Market Share by Application (2015-2020)
Table 79. Pfizer Company Details
Table 80. Pfizer Business Overview
Table 81. Pfizer Product
Table 82. Pfizer Revenue in Grand Mal Seizure Business (2015-2020) (Million US$)
Table 83. Pfizer Recent Development
Table 84. Johnson & Johnson Company Details
Table 85. Johnson & Johnson Business Overview
Table 86. Johnson & Johnson Product
Table 87. Johnson & Johnson Revenue in Grand Mal Seizure Business (2015-2020) (Million US$)
Table 88. Johnson & Johnson Recent Development
Table 89. UCB Celltech Company Details
Table 90. UCB Celltech Business Overview
Table 91. UCB Celltech Product
Table 92. UCB Celltech Revenue in Grand Mal Seizure Business (2015-2020) (Million US$)
Table 93. UCB Celltech Recent Development
Table 94. Abbott Laboratories Company Details
Table 95. Abbott Laboratories Business Overview
Table 96. Abbott Laboratories Product
Table 97. Abbott Laboratories Revenue in Grand Mal Seizure Business (2015-2020) (Million US$)
Table 98. Abbott Laboratories Recent Development
Table 99. GlaxoSmithKline Company Details
Table 100. GlaxoSmithKline Business Overview
Table 101. GlaxoSmithKline Product
Table 102. GlaxoSmithKline Revenue in Grand Mal Seizure Business (2015-2020) (Million US$)
Table 103. GlaxoSmithKline Recent Development
Table 104. Novartis Company Details
Table 105. Novartis Business Overview
Table 106. Novartis Product
Table 107. Novartis Revenue in Grand Mal Seizure Business (2015-2020) (Million US$)
Table 108. Novartis Recent Development
Table 109. Sanofi Company Details
Table 110. Sanofi Business Overview
Table 111. Sanofi Product
Table 112. Sanofi Revenue in Grand Mal Seizure Business (2015-2020) (Million US$)
Table 113. Sanofi Recent Development
Table 114. Takeda Business Overview
Table 115. Takeda Product
Table 116. Takeda Company Details
Table 117. Takeda Revenue in Grand Mal Seizure Business (2015-2020) (Million US$)
Table 118. Takeda Recent Development
Table 119. Teva Pharmaceutical Company Details
Table 120. Teva Pharmaceutical Business Overview
Table 121. Teva Pharmaceutical Product
Table 122. Teva Pharmaceutical Revenue in Grand Mal Seizure Business (2015-2020) (Million US$)
Table 123. Teva Pharmaceutical Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Grand Mal Seizure Market Share by Type: 2020 VS 2026
Figure 2. Barbiturates Features
Figure 3. Hydantoin Features
Figure 4. Phenyltriazine Features
Figure 5. Iminostilbenes Features
Figure 6. Benzodiazepines Features
Figure 7. Aliphatic Carboxylic Acid Features
Figure 8. Others Features
Figure 9. Global Grand Mal Seizure Market Share by Application: 2020 VS 2026
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Academic and Research Centers Case Studies
Figure 13. Others Case Studies
Figure 14. Grand Mal Seizure Report Years Considered
Figure 15. Global Grand Mal Seizure Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global Grand Mal Seizure Market Share by Regions: 2020 VS 2026
Figure 17. Global Grand Mal Seizure Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global Grand Mal Seizure Market Share by Players in 2019
Figure 20. Global Top Grand Mal Seizure Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Grand Mal Seizure as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Grand Mal Seizure Revenue in 2019
Figure 22. North America Grand Mal Seizure Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe Grand Mal Seizure Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China Grand Mal Seizure Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan Grand Mal Seizure Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia Grand Mal Seizure Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India Grand Mal Seizure Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America Grand Mal Seizure Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Bottom-up and Top-down Approaches for This Report
Figure 30. Data Triangulation
Figure 31. Key Executives Interviewed
発作治療の世界市場（～2026年） An epileptic seizure is a brief episode of signs or symptoms due to abnormally excessive or synchronous neuronal activity in the brain. Increasing prevalence of neurological disorders is expected to be the dominant factor driving the global seize treatment market over the forecast period. Market Ana…- 強直間代発作の世界市場（～2026年） Epilepsy is a group of neurological disorders characterized by brief, involuntary episodes of vigorous shaking of a part or complete body. The patient may experience loss or disturbance of consciousness and movements along with sensory or psychiatric disturbances. Grand mal seizures or tonic–clonic …
- 凍結療法・凍結手術の世界市場（～2026年） Cryotherapy and cryosurgery market is growing moderately. Cryotherapy, this medical practice have been used since ages. Cryotherapy and cryosurgery both these medical process are carried on using low temperature. Cryotherapy treatment uses extreme cold temperature. Cryosurgery is a part of cryothera…
- ジェルシートの世界市場（～2026年） Market Analysis and Insights: Global Gel Seat Market The global Gel Seat market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Gel Seat Scope and Market Size Gel Seat market is segmented by Type, and by Application. Players,…
- 眼瞼形成術治療の世界市場（～2026年） Market Analysis and Insights: Global Blepharoplasty Treatment Market The global Blepharoplasty Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Blepharoplasty Treatment Scope and Market Size Blepharoplasty Tre…